Stifel Financial’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Stifel Financial’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,800	Closed	-$22K	–	2608
2016 Q1	$22K	Hold	10,800	–	–	﹤0.01%	2192
2015 Q4	$27K	Buy	10,800 +400	+4%	+$1.19K	﹤0.01%	2300
2015 Q3	$27K	Buy	+10,400	New	+$27.1K	﹤0.01%	2202
2015 Q2	–	Sell	-10,000	Closed	-$29K	–	2477
2015 Q1	$29K	Sell	10,000 -1,350	-12%	-$3.45K	﹤0.01%	2253
2014 Q4	$29K	Sell	11,350 -18,340	-62%	-$80.3K	﹤0.01%	2241
2014 Q3	$221K	Buy	29,690 +15,090	+103%	+$141K	﹤0.01%	1961
2014 Q2	$172K	Sell	14,600 -1,000	-6%	-$10.7K	﹤0.01%	2034
2014 Q1	$181K	Buy	+15,600	New	+$184K	﹤0.01%	1945

Stifel Financial's SZYM Position: Q2 2016 in Review

Stifel Financial sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 10,800 shares — an estimated $22K sold.

Stifel Financial first reported a position in SZYM in Q1 2014 and held it in 8 quarters. The position peaked at $221K in Q3 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

Stifel Financial reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Stifel Financial sold 10,800 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $22K.
Stifel Financial first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 8 quarters.
Stifel Financial's SOLAZYME INC COM STK (DE) position peaked at $221K in Q3 2014.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Stifel Financial's 13F filing for Q2 2016, filed 17 Aug 2016.